首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1573921

治療計劃系統和先進影像處理市場、機會、成長動力、產業趨勢分析和預測，2024-2032 年

Treatment Planning Systems and Advanced Image Processing Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月30日 | 出版商:

Global Market Insights Inc. | 英文 280 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球治療計劃系統和先進影像處理市場價值約為 20 億美元，預計 2024 年至 2032 年複合年成長率為 8.6%。處理使用複雜的演算法增強、分析和解釋醫學影像。癌症發病率的上升和醫學影像程序的增加正在推動對治療計劃系統的需求，從而促進市場成長。使用先進影像處理技術進行精確腫瘤治療的需求也推動了全球市場的擴張。

整體治療計劃系統和先進影像處理行業根據組件、應用、技術、最終用戶和地區進行分類。

按組成部分細分市場，治療計劃系統在 2023 年帶來了 13 億美元的收入。人們對治療計劃軟體（尤其是放射治療）優勢的認知進一步推動了該細分市場的成長。醫療保健基礎設施的進步、公私合作夥伴關係以及向軟體解決方案而非傳統方法的轉變也推動了市場擴張。例如，2021年2月，富士通有限公司與多倫多大學合作，最佳化腦腫瘤和動靜脈畸形的放射治療計畫。

按應用分類，腫瘤學領域在 2023 年處於領先地位，收入為 9.948 億美元，預計複合年成長率為 8.8%。全球癌症病例激增推動了對先進腫瘤治療計劃系統的需求。成像技術的創新，特別是人工智慧驅動的影像處理和機器學習演算法，提高了治療計劃的準確性和效率，推動了市場成長。人們對各種癌症的放射治療的偏好不斷增加，這增加了對先進治療計劃軟體、最佳化放射劑量和最大限度減少副作用的需求。

在該地區強大的醫療基礎設施的推動下，北美治療計畫系統和先進影像處理市場預計到 2032 年將達到 19 億美元。 2023年，美國以8.222億美元的收入領先北美市場。美國市場的發展勢頭得益於不同年齡層癌症發病率的上升以及對先進治療計劃工具和成像技術的需求不斷增加。美國國家癌症研究所 2022 年 1 月的數據顯示，美國約有 1,810 萬名癌症倖存者，突顯了癌症管理領域對創新醫療解決方案的迫切需求。

產業生態系統分析
產業影響力
- 成長動力
  - 癌症盛行率上升
  - 影像和治療技術的持續創新
  - 轉向個人化治療
- 產業陷阱與挑戰
  - 與取得和維護先進治療計劃系統相關的巨額成本
  - 嚴格的監管要求和漫長的核准流程
成長潛力分析
未來市場趨勢
監管環境
技術景觀
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按組成部分，2021 - 2032 年

主要趨勢
先進的影像處理系統
治療計劃系統

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
腫瘤學
心臟病學
神經病學
骨科
其他應用

第 7 章：市場估計與預測：按技術分類，2021 - 2032

主要趨勢
基於 MRI 的規劃
基於 CT 的規劃
放射治療
- 3D適形放射治療
- 調強放射治療
- 影像導引放射治療
- 立體定位放射治療
質子束治療

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
門診手術中心
專科診所
其他最終用戶

第 9 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Accuray Incorporated
Agfa-Gevaert Group
Brainlab AG
Canon Medical Systems Corporation
C-RAD AB
Elekta AB
GE HealthCare Technologies Inc.
Hitachi, Ltd.
IBA Radiopharma Solutions
IntraOp Medical Corporation
Koninklijke Philips N.V.
Mercurius Health
Mirada Medical Limited
Siemens Healthineers AG
ViewRay, Inc.

簡介目錄

Product Code: 11148

The Global Treatment Planning Systems and Advanced Image Processing Market was valued at approximately USD 2 billion in 2023 and is projected to indicate a growth rate of 8.6% CAGR from 2024 to 2032. Treatment planning systems craft precise treatment plans for radiation therapy patients, while advanced image processing enhances, analyzes, and interprets medical images using sophisticated algorithms. The rising incidence of cancer and an increase in medical imaging procedures are driving demand for treatment planning systems, boosting market growth. The global market's expansion is also driven by the need for precise oncology treatments using advanced image processing technology.

The overall treatment planning systems and advanced image processing industry are classified based on the component, application, technology, end-user, and region.

Segmenting the market by component, treatment planning systems led to a revenue of USD 1.3 billion in 2023. This segment's dominance is due to the escalating cancer prevalence and the growing demand for precise oncology therapy solutions. Awareness of the benefits of treatment planning software, especially in radiotherapy, further fuels this segment's growth. Advancements in healthcare infrastructure, public-private partnerships, and a shift towards software solutions over traditional methods also drive market expansion. For instance, in February 2021, Fujitsu Limited collaborated with the University of Toronto to optimize radiation treatment plans for brain tumors and arteriovenous malformations.

By application, the oncology segment led in 2023 with a revenue of USD 994.8 million and is projected to grow at a CAGR of 8.8%. The global surge in cancer cases drives demand for advanced oncology treatment planning systems. Innovations in imaging technologies, particularly AI-driven image processing and machine learning algorithms, enhance treatment planning accuracy and efficiency, propelling market growth. The rising preference for radiotherapy for various cancers has increased demand for advanced treatment planning software, optimizing radiation dosage and minimizing side effects.

The North American market for treatment planning systems and advanced image processing is forecasted to reach USD 1.9 billion by 2032, driven by the region's robust healthcare infrastructure. In 2023, the U.S. led the North American market with a revenue of USD 822.2 million. The U.S. market's momentum is fueled by a rising cancer incidence across diverse age groups and an increasing demand for advanced treatment planning tools and imaging technologies. Data from the National Cancer Institute in January 2022 highlighted about 18.1 million cancer survivors in the U.S., underscoring the pressing demand for innovative healthcare solutions in cancer management.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of cancer
  - 3.2.1.2 Continuous innovations in imaging and treatment technologies
  - 3.2.1.3 Shift towards personalized treatment
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Significant costs associated with acquiring and maintaining advanced treatment planning systems
  - 3.2.2.2 Stringent regulatory requirements and lengthy approval processes
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Advanced image processing systems
5.3 Treatment planning systems

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Oncology
6.3 Cardiology
6.4 Neurology
6.5 Orthopedics
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 MRI-based planning
7.3 CT-based planning
7.4 Radiation therapy
- 7.4.1 3D conformal radiation therapy
- 7.4.2 Intensity-modulated radiation therapy
- 7.4.3 Image-guided radiation therapy
- 7.4.4 Stereotactic body radiation therapy
7.5 Proton beam therapy

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Specialty clinics
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa